BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34488433)

  • 1. IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced Hypertension in Mice.
    Thomas JM; Ling YH; Huuskes B; Jelinic M; Sharma P; Saini N; Ferens DM; Diep H; Krishnan SM; Kemp-Harper BK; O'Connor PM; Latz E; Arumugam TV; Guzik TJ; Hickey MJ; Mansell A; Sobey CG; Vinh A; Drummond GR
    Hypertension; 2021 Nov; 78(5):1296-1309. PubMed ID: 34488433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
    Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
    Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.
    Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR
    Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.
    Lyu B; Wang W; Ji XY; Ritter JK; Li N
    BMC Nephrol; 2020 May; 21(1):173. PubMed ID: 32393187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertension.
    Li Y; Shen M; Ferens D; Broughton BRS; Murthi P; Saini S; Widdop RE; Ricardo SD; Pinar AA; Samuel CS
    Br J Pharmacol; 2021 Mar; 178(5):1164-1181. PubMed ID: 33450051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice.
    Krishnan SM; Dowling JK; Ling YH; Diep H; Chan CT; Ferens D; Kett MM; Pinar A; Samuel CS; Vinh A; Arumugam TV; Hewitson TD; Kemp-Harper BK; Robertson AA; Cooper MA; Latz E; Mansell A; Sobey CG; Drummond GR
    Br J Pharmacol; 2016 Feb; 173(4):752-65. PubMed ID: 26103560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice.
    Li Y; Chakraborty A; Broughton BRS; Ferens D; Widdop RE; Ricardo SD; Samuel CS
    Biomed Pharmacother; 2021 Dec; 144():112256. PubMed ID: 34607108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of the interleukin 17/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+angiotensin ii-induced hypertension.
    Krebs CF; Lange S; Niemann G; Rosendahl A; Lehners A; Meyer-Schwesinger C; Stahl RA; Benndorf RA; Velden J; Paust HJ; Panzer U; Ehmke H; Wenzel UO
    Hypertension; 2014 Mar; 63(3):565-71. PubMed ID: 24366079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension.
    Wang Y; Wang DH
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1550-9. PubMed ID: 19794112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.
    Wang Y; Wang DH
    Mol Med; 2011; 17(11-12):1204-12. PubMed ID: 21792478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice.
    Jennings BL; Estes AM; Anderson LJ; Fang XR; Yaghini FA; Fan Z; Gonzalez FJ; Campbell WB; Malik KU
    Hypertension; 2012 Dec; 60(6):1510-6. PubMed ID: 23108654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension.
    Gao Y; Liu B; Guo X; Nie J; Zou H; Wen S; Yu W; Liang H
    J Hypertens; 2023 May; 41(5):794-810. PubMed ID: 36883469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension.
    Zhang J; Zhu M; Zhang S; Xie S; Gao Y; Wang Y
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107035. PubMed ID: 33045566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of CXCR6 Ameliorates Kidney Inflammation and Fibrosis in Deoxycorticosterone Acetate/Salt Hypertension.
    Wu Y; An C; Jin X; Hu Z; Wang Y
    Sci Rep; 2020 Jan; 10(1):133. PubMed ID: 31924817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2X7 deficiency attenuates hypertension and renal injury in deoxycorticosterone acetate-salt hypertension.
    Ji X; Naito Y; Weng H; Endo K; Ma X; Iwai N
    Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1207-15. PubMed ID: 22859404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension.
    Wang Y; Babánková D; Huang J; Swain GM; Wang DH
    Hypertension; 2008 Aug; 52(2):264-70. PubMed ID: 18606907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
    Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Inflammation in DOCA-Salt Hypertension.
    Banek CT; Gauthier MM; Van Helden DA; Fink GD; Osborn JW
    Hypertension; 2019 May; 73(5):1079-1086. PubMed ID: 30879356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-18 deficiency protects against renal interstitial fibrosis in aldosterone/salt-treated mice.
    Tanino A; Okura T; Nagao T; Kukida M; Pei Z; Enomoto D; Miyoshi K; Okamura H; Higaki J
    Clin Sci (Lond); 2016 Oct; 130(19):1727-39. PubMed ID: 27413021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockout of immunoproteasome subunit β2i ameliorates cardiac fibrosis and inflammation in DOCA/Salt hypertensive mice.
    Yan W; Bi HL; Liu LX; Li NN; Liu Y; Du J; Wang HX; Li HH
    Biochem Biophys Res Commun; 2017 Aug; 490(2):84-90. PubMed ID: 28478040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.